GLIFO 25 mg is a tablet containing dapagliflozin 25 mg. It is an oral antidiabetic medicine belonging to the SGLT2 inhibitor class, which helps lower blood glucose levels by increasing the removal of glucose through urine.
Uses:
Treatment of type 2 diabetes mellitus
Helps improve blood sugar control along with diet and exercise
Reduces glucose reabsorption in the kidneys
Helps manage heart failure in selected patients (as prescribed)
Used in certain cases of chronic kidney disease (as prescribed)
Dose:
Adults: Usually 10–25 mg once daily or as directed by a physician
May be taken with or without food
Take regularly at the same time each day
Dose depends on kidney function, medical condition, and treatment response
Follow the prescribed dose and duration as advised by a healthcare professional.